Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies.
Gunay UludagIrmak KaracaAmir AkhavanrezayatCigdem YasarWataru MatsumiyaBrandon Huy PhamMuhammad Sohail HalimNgoc Trong Tuong ThanYasir J SepahDiana V DoQuan Dong NguyenPublished in: Ocular immunology and inflammation (2022)
IV TCZ is a potentially effective and safe therapeutic option for the management of refractory non-infectious uveitis.